NY

Nilufa Yeasmin

Active Director Director DIN 11369191
DIN 11369191 First appointment Nov 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Nilufa Yeasmin

Data last updated:

Nilufa Yeasmin is a Director at Inmedism Healthcare Private Limited (since 2025). Inmedism Healthcare Private Limited reported revenue of ₹17.1 Lakh (FY 2025).

DIN 11369191
Primary Designation Director
First Appointment 07 Nov 2025
Oldest Company Age 3 yrs
Largest company Inmedism Healthcare Private Limited · ₹17.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inmedism Healthcare Private Limited U86100DL2023PTC412325
Director07 Nov 20252023₹17.1 Lakh (FY 2025)Active

Board colleagues of Nilufa Yeasmin

NameDINCompanyDesignation
Abu Qurayesh10111392Inmedism Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Inmedism Healthcare Private Limited
Premium access

Shareholding and investment profile for Nilufa Yeasmin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nilufa Yeasmin

Nilufa Yeasmin currently holds 1 directorship: Inmedism Healthcare Private Limited (Director, since 07 Nov 2025, revenue ₹17.1 Lakh (FY 2025)).

Nilufa Yeasmin was first appointed on 07 Nov 2025 as Director at Inmedism Healthcare Private Limited.

The current boards of Nilufa Yeasmin's companies include Abu Qurayesh (Inmedism Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available